Nurix Therapeutics, Inc. (NRIX)
USD 9.0
(-7.12%)
USD 9.0
(-7.12%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -112.16 Million USD | 127.66% |
| 2022 | 27.81 Million USD | 17.54% |
| 2021 | 23.66 Million USD | 148.63% |
| 2020 | -48.67 Million USD | -249.92% |
| 2019 | -13.91 Million USD | -353.83% |
| 2018 | -3.06 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 8 Million USD | -36.99% |
| 2024 Q1 | 12.69 Million USD | 11.36% |
| 2024 Q3 | 8.44 Million USD | 5.51% |
| 2023 FY | 63.33 Million USD | 127.66% |
| 2023 Q3 | 15.08 Million USD | -44.84% |
| 2023 Q2 | 27.34 Million USD | 187.67% |
| 2023 Q1 | 9.5 Million USD | 153.74% |
| 2023 Q4 | 11.4 Million USD | -24.4% |
| 2022 Q3 | 7.9 Million USD | -10.17% |
| 2022 Q2 | 8.8 Million USD | 19.44% |
| 2022 Q1 | 7.36 Million USD | 10.98% |
| 2022 FY | 27.81 Million USD | 17.54% |
| 2022 Q4 | 3.74 Million USD | -52.61% |
| 2021 Q3 | -20.65 Million USD | -9.26% |
| 2021 Q1 | -17.99 Million USD | -30.79% |
| 2021 FY | 23.66 Million USD | 148.63% |
| 2021 Q4 | 6.63 Million USD | 132.14% |
| 2021 Q2 | -18.9 Million USD | -5.06% |
| 2020 Q2 | -9.96 Million USD | 1.42% |
| 2020 Q4 | -13.75 Million USD | 7.39% |
| 2020 FY | -48.67 Million USD | -249.92% |
| 2020 Q3 | -14.85 Million USD | -49.14% |
| 2020 Q1 | -10.1 Million USD | 7.84% |
| 2019 Q3 | -428 Thousand USD | 67.58% |
| 2019 Q4 | -10.96 Million USD | -2461.21% |
| 2019 FY | -13.91 Million USD | -353.83% |
| 2019 Q2 | -1.32 Million USD | -10.0% |
| 2019 Q1 | -1.2 Million USD | 0.0% |
| 2018 FY | -3.06 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| AbCellera Biologics Inc. | 38.02 Million USD | 394.966% |
| Alkermes plc | 1.37 Billion USD | 108.159% |
| Agenus Inc. | 139.61 Million USD | 180.336% |
| Aptorum Group Limited | -1.11 Million USD | -9962.098% |
| Ardelyx, Inc. | 106.66 Million USD | 205.157% |
| Dyadic International, Inc. | 922.95 Thousand USD | 12252.354% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | 632.553% |
| Lantern Pharma Inc. | -174.84 Thousand USD | -64049.551% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | -739.664% |
| Novavax, Inc. | 639.93 Million USD | 117.527% |
| Janux Therapeutics, Inc. | -46.83 Million USD | -139.461% |
| Pyxis Oncology, Inc. | -2 Million USD | -5508.05% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | -21605.248% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | 688.988% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | -253726.831% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | -21182.922% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | Infinity% |
| SELLAS Life Sciences Group, Inc. | - USD | Infinity% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | -14.197% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | 14085.162% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | -136681.707% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | 182.917% |
| Clearside Biomedical, Inc. | 7.87 Million USD | 1524.99% |
| C4 Therapeutics, Inc. | -96.95 Million USD | -15.69% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | 107.389% |
| AlloVir, Inc. | -398 Thousand USD | -28081.156% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | 146.591% |
| VYNE Therapeutics Inc. | 424 Thousand USD | 26553.066% |
| Bicycle Therapeutics plc | -129.52 Million USD | 13.403% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | 93567.5% |
| ChromaDex Corporation | 50.78 Million USD | 320.876% |
| Chimerix, Inc. | 324 Thousand USD | 34717.593% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | -259.863% |
| Caribou Biosciences, Inc. | -77.59 Million USD | -44.541% |
| CRISPR Therapeutics AG | 240.95 Million USD | 146.548% |
| Precision BioSciences, Inc. | 40.47 Million USD | 377.132% |
| Fate Therapeutics, Inc. | -98.16 Million USD | -14.26% |
| Fortress Biotech, Inc. | 57.85 Million USD | 293.872% |
| Fortress Biotech, Inc. | 57.85 Million USD | 293.872% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | 776.606% |
| ImmuCell Corporation | 4.39 Million USD | 2651.268% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | -5.69% |
| Immix Biopharma, Inc. | -5468.00 USD | -2051125.311% |
| Incyte Corporation | 3.44 Billion USD | 103.26% |
| Innoviva, Inc. | 261.06 Million USD | 142.963% |
| IO Biotech, Inc. | -756 Thousand USD | -14736.111% |
| Jaguar Health, Inc. | 7.72 Million USD | 1552.11% |
| Keros Therapeutics, Inc. | -664 Thousand USD | -16791.717% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | 193.66% |
| ContextLogic Inc. | 59 Million USD | 290.103% |
| MiMedx Group, Inc. | 266.84 Million USD | 142.033% |
| MEI Pharma, Inc. | 49.32 Million USD | 327.383% |
| NextCure, Inc. | -3.68 Million USD | -2944.544% |
| Onconetix, Inc. | -1.12 Million USD | -9850.717% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | -287.189% |
| Opthea Limited | 21.72 Thousand USD | 516495.028% |
| Psyence Biomedical Ltd. | -240.00 USD | -46733650.0% |
| Vaxcyte, Inc. | -75 Million USD | -49.548% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | -195554.677% |
| Precigen, Inc. | 106 Thousand USD | 105912.264% |
| Pharming Group N.V. | 220.1 Million USD | 150.958% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | 21878.835% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | 11216.056% |
| PureTech Health plc | -1.6 Million USD | -6896.943% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | 202.176% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 38.172% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | Infinity% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | -147.459% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | -410.124% |
| Acelyrin, Inc. | -115 Thousand USD | -97431.304% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | -1115818.814% |
| Summit Therapeutics Inc. | -2.05 Million USD | -5371.268% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | -19542.907% |
| Senti Biosciences, Inc. | -2.68 Million USD | -4080.432% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | 2868.724% |
| Elevation Oncology, Inc. | -39 Thousand USD | -287492.308% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | -2237.662% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | -2745.247% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | 485.049% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | 22713.105% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | -203829.091% |
| Wave Life Sciences Ltd. | 104.09 Million USD | 207.745% |
| Seer, Inc. | 7.02 Million USD | 1696.143% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | 2661.923% |
| Aadi Bioscience, Inc. | 21.54 Million USD | 620.589% |
| ESSA Pharma Inc. | -118.49 Thousand USD | -94557.822% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | -78169.517% |
| GT Biopharma, Inc. | - USD | Infinity% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | 18517.241% |
| Akebia Therapeutics, Inc. | 120.47 Million USD | 193.1% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | 135.757% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | -2243120.0% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | 4457.459% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | -220950.453% |
| Sorrento Therapeutics, Inc. | 29.38 Million USD | 481.669% |
| TRACON Pharmaceuticals, Inc. | -232 Thousand USD | -48245.259% |
| Viracta Therapeutics, Inc. | -492 Thousand USD | -22696.951% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | -1480.178% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | -23535.482% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | -1078371.154% |
| Soligenix, Inc. | 97.31 Thousand USD | 115360.351% |
| Century Therapeutics, Inc. | -10.8 Million USD | -937.663% |
| Kura Oncology, Inc. | -849 Thousand USD | -13110.954% |
| TScan Therapeutics, Inc. | -67.1 Million USD | -67.145% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | -76200.0% |
| Ocean Biomedical, Inc. | - USD | Infinity% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | 213.249% |
| Autolus Therapeutics plc | -4.86 Million USD | -2204.52% |
| Mineralys Therapeutics, Inc. | - USD | Infinity% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | 371.012% |
| Eterna Therapeutics Inc. | -168 Thousand USD | -66662.5% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | 218.409% |
| GRI Bio, Inc. | 10.84 Million USD | 1134.6% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | 4515.812% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | -1191.136% |
| IGM Biosciences, Inc. | -211.66 Million USD | 47.009% |
| INmune Bio, Inc. | 155 Thousand USD | 72461.935% |
| Heron Therapeutics, Inc. | 61.93 Million USD | 281.083% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | -7346.171% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | -17196.678% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | -383042.037% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | 28000.746% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | -5519.289% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | -35734.185% |
| Coherus BioSciences, Inc. | 94.46 Million USD | 218.738% |
| Verastem, Inc. | -62 Thousand USD | -180804.839% |
| Abeona Therapeutics Inc. | 2.43 Million USD | 4706.201% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | -42873.563% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | 3805.352% |
| Histogen Inc. | 3.76 Million USD | 3075.882% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | 19566.346% |
| Surrozen, Inc. | -27.23 Million USD | -311.902% |
| Organovo Holdings, Inc. | -5.38 Million USD | -1981.295% |
| Lixte Biotechnology Holdings, Inc. | - USD | Infinity% |
| Ovid Therapeutics Inc. | -1.2 Million USD | -9208.894% |
| Panbela Therapeutics, Inc. | -25.64 Million USD | -337.326% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | 659.351% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | -5664596.97% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | 1948.882% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | -166977.803% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | 172.46% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | 77027.984% |
| Apollomics, Inc. | 127 Thousand USD | 88415.748% |
| Amarin Corporation plc | 165.54 Million USD | 167.754% |
| Mesoblast Limited | -9.81 Million USD | -1042.751% |
| Turnstone Biologics Corp. | 16.5 Million USD | 779.517% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | -1.513% |
| Synaptogenix, Inc. | -6347.00 USD | -1767049.835% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | -219823.529% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | 169.508% |
| BriaCell Therapeutics Corp. | - USD | Infinity% |
| Monopar Therapeutics Inc. | - USD | Infinity% |
| Exelixis, Inc. | 1.75 Billion USD | 106.381% |
| Better Therapeutics, Inc. | -2.72 Million USD | -4009.967% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | 133.176% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | -983078.471% |
| Dermata Therapeutics, Inc. | - USD | Infinity% |
| Aridis Pharmaceuticals, Inc. | - USD | Infinity% |
| Gritstone bio, Inc. | -6.26 Million USD | -1691.709% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | -10022.834% |
| TNF Pharmaceuticals, Inc. | - USD | Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | 1632.673% |
| Insmed Incorporated | 239.63 Million USD | 146.805% |
| Virpax Pharmaceuticals, Inc. | - USD | Infinity% |
| MediWound Ltd. | 3.57 Million USD | 3234.74% |
| OmniAb, Inc. | 14.66 Million USD | 864.717% |
| Alector, Inc. | -95.05 Million USD | -17.998% |
| Seres Therapeutics, Inc. | 125.62 Million USD | 189.285% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | -158.061% |
| Zai Lab Limited | 170.9 Million USD | 165.628% |
| Revance Therapeutics, Inc. | 81.87 Million USD | 236.987% |
| Aura Biosciences, Inc. | -1.29 Million USD | -8561.081% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | 86377.692% |
| Immunic, Inc. | -111 Thousand USD | -100945.946% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | 807.462% |
| Veracyte, Inc. | 248.14 Million USD | 145.199% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 98.395% |
| FibroGen, Inc. | 128.9 Million USD | 187.011% |
| SeaStar Medical Holding Corporation | - USD | Infinity% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | -19886602.128% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | -861.362% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 103.3% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | 28933.162% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | 131.564% |
| TG Therapeutics, Inc. | 219.1 Million USD | 151.19% |
| Galecto, Inc. | -830 Thousand USD | -13413.373% |
| Calithera Biosciences, Inc. | -1.38 Million USD | -7998.267% |
| Fortrea Holdings Inc. | 424 Million USD | 126.453% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | -30.167% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | -19681.481% |
| XBiotech Inc. | -1.74 Million USD | -6331.25% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | -10022.834% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | -141.357% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | -48.491% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | 252.802% |
| Theravance Biopharma, Inc. | 16.8 Million USD | 767.506% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | 128.83% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | -125.917% |
| Vaxxinity, Inc. | -2.23 Million USD | -4920.636% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | 134.326% |
| Gain Therapeutics, Inc. | -11.32 Million USD | -890.485% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | 558.717% |
| NexImmune, Inc. | -1.02 Million USD | -10842.836% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | 2077155.556% |
| Marker Therapeutics, Inc. | -7.1 Million USD | -1478.475% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 100.992% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | -167737.85% |
| Scopus BioPharma Inc. | - USD | Infinity% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | -3058.575% |
| Ainos, Inc. | -253.73 Thousand USD | -44104.341% |
| Pluri Inc. | 322 Thousand USD | 34932.609% |
| Prothena Corporation plc | -129.2 Million USD | 13.189% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | 322.436% |
| Celularity Inc. | 6.75 Million USD | 1760.415% |
| Rallybio Corporation | -150 Thousand USD | -74674.0% |
| Cue Biopharma, Inc. | -32.6 Million USD | -243.978% |
| MeiraGTx Holdings plc | 287 Thousand USD | 39180.488% |
| Omeros Corporation | -69.77 Million USD | -60.737% |
| Humacyte, Inc. | -76.55 Million USD | -46.52% |
| Immunocore Holdings plc | 248.39 Million USD | 145.155% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | -639.409% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | 279.797% |
| Blueprint Medicines Corporation | 236.58 Million USD | 147.409% |
| CalciMedica, Inc. | -58 Thousand USD | -193281.034% |
| Cabaletta Bio, Inc. | -1.42 Million USD | -7765.428% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | 486.03% |
| Scholar Rock Holding Corporation | -2.84 Million USD | -3843.776% |
| Sana Biotechnology, Inc. | -30.86 Million USD | -263.392% |
| Pulmatrix, Inc. | -8.22 Million USD | -1264.489% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | -9486.41% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | -28010.526% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 71.875% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | 4140.986% |
| Cytokinetics, Incorporated | -322.59 Million USD | 65.231% |
| Eloxx Pharmaceuticals, Inc. | - USD | Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | 13110.132% |
| Protara Therapeutics, Inc. | -341 Thousand USD | -32791.789% |
| Vor Biopharma Inc. | -3.49 Million USD | -3111.942% |
| Roivant Sciences Ltd. | 109.23 Million USD | 202.679% |
| Evogene Ltd. | 1.39 Million USD | 8117.227% |
| ProKidney Corp. | -3.16 Million USD | -3439.318% |
| Applied Therapeutics, Inc. | -43.91 Million USD | -155.422% |
| Hoth Therapeutics, Inc. | - USD | Infinity% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | 1735.715% |
| CorMedix Inc. | -205.56 Thousand USD | -54463.1% |
| BioLineRx Ltd. | 1.1 Million USD | 10222.834% |
| Tango Therapeutics, Inc. | -78.67 Million USD | -42.57% |
| Galectin Therapeutics Inc. | -33 Thousand USD | -339781.818% |
| Atai Life Sciences N.V. | -5000.00 USD | -2243120.0% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | -91941.622% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | -116734.375% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | -7974.946% |
| Sagimet Biosciences Inc. | 2 Million USD | 5708.05% |
| MediciNova, Inc. | 979.7 Thousand USD | 11548.446% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | -33.02% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | -118519.851% |
| GeoVax Labs, Inc. | -20.72 Million USD | -441.298% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | 145.867% |
| Biomea Fusion, Inc. | -4.2 Million USD | -2569.864% |
| PTC Therapeutics, Inc. | 872.33 Million USD | 112.858% |
| Mereo BioPharma Group plc | 7.42 Million USD | 1610.382% |
| Cullinan Oncology, Inc. | -310 Thousand USD | -36080.968% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | -934575.0% |
| Absci Corporation | -41.84 Million USD | -168.014% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | -2243120.0% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | -46.859% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | -4457.538% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | 152.477% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | -11819.341% |
| Allakos Inc. | -6.14 Million USD | -1726.429% |
| Imunon, Inc. | -720 Thousand USD | -15477.808% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | -62.562% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | 123.568% |
| BioAtla, Inc. | -103.73 Million USD | -8.127% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | -983078.471% |
| Bio-Path Holdings, Inc. | -178 Thousand USD | -62911.798% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 53.809% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | -35964.63% |
| XOMA Corporation | 3.86 Million USD | 3004.973% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | -60.036% |
| Cara Therapeutics, Inc. | 14.79 Million USD | 858.152% |
| aTyr Pharma, Inc. | -2.38 Million USD | -4596.859% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | 1000.169% |
| Akero Therapeutics, Inc. | -29 Thousand USD | -386662.069% |
| Viridian Therapeutics, Inc. | -1 Million USD | -11027.083% |
| Eliem Therapeutics, Inc. | - USD | Infinity% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | 862777023.077% |
| Akari Therapeutics, Plc | -4000.00 USD | -2803925.0% |
| Tevogen Bio Holdings Inc. | - USD | Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | 117.611% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | 57704.721% |
| UroGen Pharma Ltd. | 73.35 Million USD | 252.908% |
| Sutro Biopharma, Inc. | -26.69 Million USD | -320.173% |
| ZIVO Bioscience, Inc. | 11.61 Thousand USD | 966172.351% |
| Orgenesis Inc. | -5.72 Million USD | -1859.144% |
| Entera Bio Ltd. | -56 Thousand USD | -200187.5% |
| GH Research PLC | -315 Thousand USD | -35506.667% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | -59244.444% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | -21264.0% |
| Xencor, Inc. | -85.26 Million USD | -31.552% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | -50656.866% |
| Replimune Group, Inc. | -2.65 Million USD | -4124.52% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | -11102.254% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | 163.067% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | 57704.721% |
| Portage Biotech Inc. | -54 Thousand USD | -207605.556% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | -118519.851% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | -29650.928% |
| OncoCyte Corporation | 413 Thousand USD | 27257.627% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | -2495139.155% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | -50522872.973% |
| Purple Biotech Ltd. | -196 Thousand USD | -57125.0% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | 1350.68% |
| scPharmaceuticals Inc. | 9.78 Million USD | 1246.606% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | -973.829% |
| HilleVax, Inc. | -2.15 Million USD | -5102.273% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | -115529.897% |
| Tharimmune, Inc. | - USD | Infinity% |
| Genprex, Inc. | -15 Thousand USD | -747440.656% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | -16690.569% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | -487556.522% |
| XTL Biopharmaceuticals Ltd. | - USD | Infinity% |
| Virios Therapeutics, Inc. | - USD | Infinity% |
| OKYO Pharma Limited | -7506.16 USD | -1494152.72% |
| Savara Inc. | -44.26 Million USD | -153.402% |
| Curis, Inc. | 9.81 Million USD | 1243.217% |
| Daré Bioscience, Inc. | 2.76 Million USD | 4149.832% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | -89781.239% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | -6387.045% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | -49093.421% |
| BeiGene, Ltd. | 2.07 Billion USD | 105.395% |
| Kiromic BioPharma, Inc. | -2.79 Million USD | -3911.624% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 71.936% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | 297.857% |
| Erasca, Inc. | -3.73 Million USD | -2905.386% |
| bluebird bio, Inc. | -4.03 Million USD | -2683.151% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | -397380.332% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | 105.89% |
| DBV Technologies S.A. | 15.72 Million USD | 813.129% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | -397380.332% |
| Moderna, Inc. | 2.15 Billion USD | 105.205% |
| Vincerx Pharma, Inc. | -915 Thousand USD | -12158.033% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | 1500.962% |
| Molecular Templates, Inc. | 50.39 Million USD | 322.564% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | -20825.56% |
| Travere Therapeutics, Inc. | 133.78 Million USD | 183.835% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | -1702.652% |
| Spruce Biosciences, Inc. | -39.34 Million USD | -185.085% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | -0.93% |
| Cogent Biosciences, Inc. | -3.58 Million USD | -3026.003% |
| MacroGenics, Inc. | 50.52 Million USD | 321.982% |
| RenovoRx, Inc. | - USD | Infinity% |
| Adicet Bio, Inc. | -6.09 Million USD | -1739.308% |
| Prime Medicine, Inc. | -147.9 Million USD | 24.167% |
| Aditxt, Inc. | -111.66 Thousand USD | -100348.684% |
| Adagene Inc. | 18.11 Million USD | 719.281% |
| Estrella Immunopharma, Inc. | - USD | Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | 23083.811% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | 180.0% |
| Acurx Pharmaceuticals, Inc. | - USD | Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | 171.062% |
| SciSparc Ltd. | 2.19 Million USD | 5207.514% |
| Vericel Corporation | 135.57 Million USD | 182.729% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | -447666.378% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | -361919.883% |
| Generation Bio Co. | -73.91 Million USD | -51.751% |
| Astria Therapeutics, Inc. | - USD | Infinity% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | -25566.133% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | 305.352% |
| Invivyd, Inc. | -2.02 Million USD | -5430.621% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 62.718% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | -108333.071% |
| Spero Therapeutics, Inc. | 96.36 Million USD | 216.388% |
| Artelo Biosciences, Inc. | - USD | Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | 214.115% |
| ADMA Biologics, Inc. | 88.21 Million USD | 227.141% |
| Clene Inc. | 533 Thousand USD | 21143.34% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | 565.221% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | -11620.063% |
| GeoVax Labs, Inc. | -20.72 Million USD | -441.298% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | 5741.901% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | -57620.929% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | 325.2% |
| Relmada Therapeutics, Inc. | - USD | Infinity% |
| Finch Therapeutics Group, Inc. | -7.09 Million USD | -1481.514% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | -13316.388% |
| Vir Biotechnology, Inc. | 83.41 Million USD | 234.461% |
| Evaxion Biotech A/S | 73.11 Thousand USD | 153509.837% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | 310.98% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 35.237% |
| Trevena, Inc. | 1.45 Million USD | 7808.66% |
| Surrozen, Inc. | -27.23 Million USD | -311.902% |
| Tyra Biosciences, Inc. | -353 Thousand USD | -31673.654% |
| Cingulate Inc. | -582.91 Thousand USD | -19141.3% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | -361709.677% |
| Unity Biotechnology, Inc. | -19.69 Million USD | -469.374% |
| Tenax Therapeutics, Inc. | -7570.00 USD | -1481551.255% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | -12631.101% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | 116.477% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | -11252.328% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | -198971.74% |
| Kronos Bio, Inc. | 1.37 Million USD | 8275.0% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | -108.998% |
| CERo Therapeutics Holdings, Inc. | - USD | Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | -38311.301% |
| Statera Biopharma, Inc. | -488.31 Thousand USD | -22869.032% |
| ImmunityBio, Inc. | -17.89 Million USD | -526.948% |
| Korro Bio, Inc. | -3.63 Million USD | -2989.835% |
| Kineta, Inc. | 5.43 Million USD | 2164.44% |
| BioVie Inc. | -229.37 Thousand USD | -48798.102% |
| Codexis, Inc. | 57.33 Million USD | 295.627% |
| Celularity Inc. | 6.75 Million USD | 1760.415% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | 2894.941% |
| Celcuity Inc. | -142.77 Thousand USD | -78459.521% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | 221805.871% |
| Cibus, Inc. | 1.42 Million USD | 7987.553% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | -29889.572% |
| eFFECTOR Therapeutics, Inc. | -22.91 Million USD | -389.38% |
| IN8bio, Inc. | -2.5 Million USD | -4384.646% |
| Kodiak Sciences Inc. | -25.94 Million USD | -332.27% |
| Annexon, Inc. | -3.26 Million USD | -3333.15% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | -5387.329% |
| Assembly Biosciences, Inc. | -41.73 Million USD | -168.733% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | 17625.156% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | 114.407% |
| Eyenovia, Inc. | - USD | Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | 164.85% |
| Conduit Pharmaceuticals Inc. | - USD | Infinity% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | -5803.211% |
| Arcellx, Inc. | 108.27 Million USD | 203.585% |
| Cardiff Oncology, Inc. | -32.36 Million USD | -246.507% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | 241.61% |
| Regulus Therapeutics Inc. | -21.15 Million USD | -430.262% |
| Moolec Science SA | -143.3 Thousand USD | -78167.332% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | -165.043% |
| Geron Corporation | -123.5 Million USD | 9.184% |
| LAVA Therapeutics N.V. | 3.28 Million USD | 3512.26% |
| Royalty Pharma plc | 1.79 Billion USD | 106.252% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | -60.024% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | -3105132.558% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | 48572.499% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | -0.67% |
| Humacyte, Inc. | -76.55 Million USD | -46.52% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | -11716.695% |
| 89bio, Inc. | -273 Thousand USD | -40984.615% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | -8822.912% |
| Avenue Therapeutics, Inc. | - USD | Infinity% |
| Genelux Corporation | -848 Thousand USD | -13126.533% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | -91087.805% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | 10123.324% |
| Notable Labs, Ltd. | 113 Thousand USD | 99357.522% |
| Liquidia Corporation | 14.6 Million USD | 868.226% |
| Mustang Bio, Inc. | -2.22 Million USD | -4940.944% |
| Immunovant, Inc. | -231 Thousand USD | -48454.545% |
| Quantum-Si incorporated | 488 Thousand USD | 23083.811% |
| Arbutus Biopharma Corporation | -55.55 Million USD | -101.877% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | -373770.0% |
| Vera Therapeutics, Inc. | 1.86 Million USD | 6123.684% |
| Acasti Pharma Inc. | -11 Thousand USD | -1019545.455% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | -54715.094% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | -17196.678% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 33.043% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | 9985.685% |
| NeuroBo Pharmaceuticals, Inc. | - USD | Infinity% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | -29338.583% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | -5628.345% |
| PepGen Inc. | -1.18 Million USD | -9373.057% |
| Moleculin Biotech, Inc. | -127 Thousand USD | -88215.748% |
| United Therapeutics Corporation | 2.07 Billion USD | 105.418% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -389.85% |
| Solid Biosciences Inc. | -76.56 Million USD | -46.495% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | -135716.088% |
| Immuneering Corporation | -764.13 Thousand USD | -14578.108% |
| Lixte Biotechnology Holdings, Inc. | - USD | Infinity% |
| Silo Pharma, Inc. | 66.26 Thousand USD | 169363.854% |
| Belite Bio, Inc | -399 Thousand USD | -28010.526% |
| XOMA Corporation | 3.86 Million USD | 3004.973% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | -459.797% |
| Bionomics Limited | -434.44 Thousand USD | -25716.839% |
| Apogee Therapeutics, Inc. | - USD | Infinity% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | -10343.296% |
| uniQure N.V. | 2.21 Million USD | 5163.702% |
| Cassava Sciences, Inc. | -89.42 Million USD | -25.427% |
| Estrella Immunopharma, Inc. | - USD | Infinity% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | -21.823% |
| Forte Biosciences, Inc. | -9000.00 USD | -1246133.333% |
| Anebulo Pharmaceuticals, Inc. | - USD | Infinity% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | -13332.455% |
| Conduit Pharmaceuticals Inc. | - USD | Infinity% |
| SeaStar Medical Holding Corporation | - USD | Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | -25566.133% |
| Altimmune, Inc. | -65.37 Million USD | -71.571% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | 130.981% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | -10343.296% |
| Compugen Ltd. | 31.45 Million USD | 456.576% |
| Peak Bio, Inc. | 367.76 Thousand USD | 30597.677% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | 557.501% |
| Benitec Biopharma Inc. | 108 Thousand USD | 103952.778% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | -143696.154% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | -9223.441% |
| Zura Bio Limited | - USD | Infinity% |
| PolyPid Ltd. | -1.82 Million USD | -6055.928% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | -94152.941% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | -9223.441% |
| Instil Bio, Inc. | -4.75 Million USD | -2258.305% |
| argenx SE | 1.1 Billion USD | 110.118% |
| Immunome, Inc. | -8.9 Million USD | -1159.246% |
| Compass Therapeutics, Inc. | -1.89 Million USD | -5834.444% |
| Verona Pharma plc | -679.62 Thousand USD | -16403.39% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | -63992.0% |
| Shattuck Labs, Inc. | -2.38 Million USD | -4602.767% |
| CervoMed Inc. | -1.29 Million USD | -8570.274% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | -4559.784% |
| Plus Therapeutics, Inc. | -4.77 Million USD | -2247.938% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | 4639.093% |
| Moolec Science SA | -143.3 Thousand USD | -78167.332% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | -27388.42% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | -4098.384% |
| AnaptysBio, Inc. | 14.78 Million USD | 858.819% |
| Design Therapeutics, Inc. | -537 Thousand USD | -20786.592% |
| Leap Therapeutics, Inc. | -427 Thousand USD | -26167.213% |
| NeurAxis, Inc. | 2.15 Million USD | 5300.575% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | 5326.514% |
| Lumos Pharma, Inc. | 2 Million USD | 5688.49% |
| Achilles Therapeutics plc | -4.73 Million USD | -2270.633% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | -63992.0% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | -106037.686% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | 454.281% |
| CERo Therapeutics Holdings, Inc. | - USD | Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | 13110.132% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | -10768.314% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | -146.248% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | 260939.535% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | -13544.891% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | -852316.781% |
| Palisade Bio, Inc. | 246 Thousand USD | 45693.902% |
| Tourmaline Bio, Inc. | -33 Thousand USD | -339781.818% |
| Beam Therapeutics Inc. | -59.67 Million USD | -87.963% |
| Neurogene Inc. | -3.26 Million USD | -3338.412% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | 180.497% |
| AEON Biopharma, Inc. | - USD | Infinity% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | -2937.947% |
| Sesen Bio, Inc. | 40 Million USD | 380.403% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | -37664.646% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | -2685.199% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | -1072.496% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | 896.598% |
| Athira Pharma, Inc. | -969 Thousand USD | -11474.923% |
| Vaccinex, Inc. | -16 Million USD | -600.831% |
| HCW Biologics Inc. | -574.82 Thousand USD | -19412.233% |
| XOMA Corporation | 3.86 Million USD | 3004.973% |
| Nektar Therapeutics | 53.47 Million USD | 309.733% |
| Arvinas, Inc. | 71.8 Million USD | 256.213% |
| Tevogen Bio Holdings Inc. | - USD | Infinity% |
| Merus N.V. | -83.46 Million USD | -34.387% |
| Omega Therapeutics, Inc. | -62.77 Million USD | -78.671% |
| Quince Therapeutics, Inc. | -322 Thousand USD | -34732.609% |
| Rezolute, Inc. | -36 Thousand USD | -311458.333% |
| Clene Inc. | 533 Thousand USD | 21143.34% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | -8735180.374% |
| BeyondSpring Inc. | 1.75 Million USD | 6505.54% |
| Synlogic, Inc. | -1.92 Million USD | -5729.574% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | -303037.838% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | -1671.336% |
| Peak Bio, Inc. | 367.76 Thousand USD | 30597.677% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | -491.473% |
| Krystal Biotech, Inc. | 47.6 Million USD | 335.608% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | 179.496% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | 2332.06% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | -4231.847% |
| MannKind Corporation | 136.19 Million USD | 182.356% |
| Ikena Oncology, Inc. | -50.49 Million USD | -122.136% |
| Cyclerion Therapeutics, Inc. | - USD | Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | 203.076% |
| Gossamer Bio, Inc. | -4.38 Million USD | -2457.834% |
| CohBar, Inc. | - USD | Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | -44408.333% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | -2243120.0% |
| Legend Biotech Corporation | 140.92 Million USD | 179.587% |
| Mural Oncology plc | -2.56 Million USD | -4269.342% |
| Biora Therapeutics, Inc. | -551 Thousand USD | -20255.898% |
| PaxMedica, Inc. Common Stock | - USD | Infinity% |
| Disc Medicine, Inc. | -100 Thousand USD | -112061.0% |
| Champions Oncology, Inc. | 20.75 Million USD | 640.431% |
| REGENXBIO Inc. | 53.02 Million USD | 311.509% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | -1993.746% |
| Anavex Life Sciences Corp. | - USD | Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | -58203.314% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | -6375.808% |
| Vaxart, Inc. | -60.76 Million USD | -84.588% |
| PharmaCyte Biotech, Inc. | - USD | Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | -42582.472% |
| Cellectis S.A. | 18 Thousand USD | 623216.667% |
| Longeveron Inc. | 221 Thousand USD | 50851.584% |
| Repare Therapeutics Inc. | -80.07 Million USD | -40.079% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | 110.262% |
| Inozyme Pharma, Inc. | -1.29 Million USD | -8567.774% |
| Revolution Medicines, Inc. | -399.66 Million USD | 71.936% |
| Nymox Pharmaceutical Corporation | - USD | Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | -320360.0% |
| ArriVent BioPharma, Inc. Common Stock | - USD | Infinity% |
| AN2 Therapeutics, Inc. | - USD | Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | 229000.0% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 101.303% |
| Denali Therapeutics Inc. | -93.34 Million USD | -20.157% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | -447666.378% |
| Veru Inc. | 7.56 Million USD | 1582.449% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | -74178.808% |
| Cingulate Inc. | -582.91 Thousand USD | -19141.3% |
| Passage Bio, Inc. | -3.72 Million USD | -2914.27% |
| Context Therapeutics Inc. | -12.04 Thousand USD | -931160.379% |
| Exicure, Inc. | -1.42 Million USD | -7782.01% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | -29184.856% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | 4249.501% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | -21777.603% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | 264.638% |
| Nuvalent, Inc. | - USD | Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | -74870.423% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | -89.442% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | 28785.678% |
| OmniAb, Inc. | 14.66 Million USD | 864.717% |
| Anew Medical, Inc. | - USD | Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | 661.001% |
| Lipocine Inc. | -2.85 Million USD | -3834.344% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | -5985.784% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | -1866.012% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | -7346.171% |
| G1 Therapeutics, Inc. | 75.31 Million USD | 248.921% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | -172455.385% |
| Sage Therapeutics, Inc. | 84.29 Million USD | 233.056% |
| Ocugen, Inc. | -33.53 Million USD | -234.44% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | -3447.154% |
| Q32 Bio Inc. | 578 Thousand USD | 19505.017% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | -42224.906% |
| Alumis Inc. Common Stock | -1.28 Million USD | -8635.28% |
| Equillium, Inc. | 35.95 Million USD | 411.922% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | -6470.65% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | 22501.778% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | -2713034.978% |
| Galera Therapeutics, Inc. | -259 Thousand USD | -43205.405% |
| Evelo Biosciences, Inc. | - USD | Infinity% |
| Comera Life Sciences Holdings, Inc. | 422.71 Thousand USD | 26633.668% |
| Dominari Holdings Inc. | 2.03 Million USD | 5600.785% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | -61032.822% |
| vTv Therapeutics Inc. | -13.59 Million USD | -725.017% |
| Bio-Techne Corporation | 773.07 Million USD | 114.508% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | 747.618% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | 124.341% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | -9494.611% |
| Candel Therapeutics, Inc. | -23.98 Million USD | -367.727% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | 1058.887% |
| Nkarta, Inc. | -5.86 Million USD | -1811.075% |
| BioCardia, Inc. | -7.24 Million USD | -1447.262% |
| Iterum Therapeutics plc | -1.75 Million USD | -6309.2% |